UNSPSC 51183403: Nateglinide

This classification denotes an anti-diabetic agent with the molecular formula C19H27NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 41X3PWK4O2, chemically known as d-phenylalanine, n-((4-(1-methylethyl)cyclohexyl)carbonyl)-, trans- but more generally known as nateglinide, which bears US NIH Compound Identifier 60026. European Medicines Agency schedules Nateglinide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09170MIG.

UNSPSC 51183403 Nateglinide is a Commodity code for a meglitinide-class oral antidiabetic pharmaceutical used to manage blood glucose in patients with type 2 diabetes. State and local governments procure nateglinide primarily through pharmacy benefit managers, group purchasing organizations, and direct pharmaceutical contracts to support Medicaid programs, correctional health services, and public health clinics. The issuing bodies are typically state Medicaid agencies, departments of corrections, county health departments, and municipal health systems that maintain formularies and negotiate volume pricing with pharmaceutical suppliers.

The source provided contains no recent state or local contract opportunities tagged to this code, preventing characterization of geographic spread, issuing-body concentration, or representative solicitations. Without posted RFP, RFQ, IFB, or ITB records, activity cannot be assessed for pursuit timing.